 |
Allogeneic stem cell transplantation / edited by Hillard M. Lazarus and Mary J. Laughlin. — 2nd ed. — Totowa, N.J. : Humana, 2010. – (64.881/A441/2nd ed.) |
Contents
Contents
1 Allogeneic Stem Cell Transplantation: The Last Century
2 Full Intensity and Reduced Intensity Allogeneic Transplantation in AML
3 Allogeneic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia (ALL)
4 Hematopoietic Progenitor Cell Transplantation for Treatment of Chronic Lymphocytic Leukemia
5 The Role of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia Patients in the Era of Tyrosine Kinase Inhibitors
6 Allogeneic Transplantation for Hodgkin's Lymphoma
7 Myeloablative Allogeneic Stem Cell Transplantation for Non-Hodgkin's Lymphoma
8 Non-Hodgkin's Lymphoma: Allogeneic Reduced Intensity Conditioning
9 The Role of Allogeneic Transplantation for Multiple Myeloma in Older Adults
10 Single Versus Tandem Autologous Hematopoietic Stem Cell Transplant in Multiple Myeloma
11 Treatment Strategies for Follicular Center Cell Non-Hodgkin's Lymphoma
12 The Role of Transplantation in Favorable-Risk Acute Myeloid Leukemia
13 Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukaemia in Adults
14 Allogeneic Transplantation for Myelodysplastic Syndromes 203
15 Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia
16 Allogeneic Transplantation for the Treatment of Multiple Myeloma 261
17 Blood Vs. Marrow Allogeneic Stem Cell Transplantation
18 Hematopoietic Cell Transplantation from Partially HLA-Mismatched (HLA-Haploidentical) Related Donors 299
19 Unrelated Donor Transplants
20 Update on Umbilical Cord Blood Transplantation 363
21 Selection of Cord Blood Unit(s) for Transplantation 375
22 Mobilization of Hematopoietic Cells Prior to Autologous or Allogeneic Transplantation
23 Natural Killer-Cell Based Treatment in Hematopoetic Stem Cell Transplantation
24 Cryopreservation of Allogeneic Stem Cell Products 427
25 Concepts and Controversies in the Use of Novel Preparative Regimens for Allogeneic Stem Cell Transplantation 441
26 Allogeneic Haematopoietic Stem Cell Transplantation and Natural Killer Cell Alloreactivity
27 Therapeutic Potential of Mesenchymal Stem Cells in Hematopoietic Stem Cell Transplantation
28 Hematopoietic Stem Cell Transplantation for Thalassemia 491
29 Viral Infections in Hematopoietic Stem Cell Transplant Recipients
30 Fungal Infections
31 Immune Reconstitution and Implications for Immunotherapy Following Hematopoeitic Stem Cell Transplantation
32 Acute Graft Versus Host Disease: Prophylaxis 565
33 Chronic Graft-Versus-Host Disease
34 Post-transplant Lymphoproliferative Disorder 597
35 Psychological Care of Adult Allogeneic Transplant Patients 619
36 Second Allogeneic Transplantation: Outcomes and Indications 657
37 Minimal Residual Disease
38 Functional Assessment Tools and Co-morbidity Scoring in Hematopoietic Progenitor Cell Transplantation
39 Unique Thrombotic and Hemostatic Complications Associated with Allogeneic Hematopoietic Stem Cell Transplantation 695
40 How Much Isolation Is Enough for Allografls?
41 Monoclonal Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
42 Treatment of Acute Graft-vs-Host Disease 747
43 The Importance of Non-Human Primate Models for Pre-clinical Studies in Hematopoiesis 767
44 In Vivo Models of Allogeneic Hematopoietic Stem Cell Transplantation
45 Dendritic Cells
46 Augmentation of Hematopoietic Stem Cell Transplantation with Anti-cancer Vaccines
Index
